Bispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232

.

Source: Expert Opinion on Therapeutic Patents - August 23, 2020 Category: Drugs & Pharmacology Authors: Nemesio Villa-Ruano Tayde Guerrero-Gonz ález Eduardo G ómez-Conde Martin Perez-Santos Source Type: research